220 related articles for article (PubMed ID: 11037889)
1. Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression.
Kingsbury DJ; Mear JP; Witte DP; Taurog JD; Roopenian DC; Colbert RA
Arthritis Rheum; 2000 Oct; 43(10):2290-6. PubMed ID: 11037889
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides.
Khare SD; Bull MJ; Hanson J; Luthra HS; David CS
J Immunol; 1998 Jan; 160(1):101-6. PubMed ID: 9551961
[TBL] [Abstract][Full Text] [Related]
3. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
[TBL] [Abstract][Full Text] [Related]
4. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.
Khare SD; Hansen J; Luthra HS; David CS
J Clin Invest; 1996 Dec; 98(12):2746-55. PubMed ID: 8981920
[TBL] [Abstract][Full Text] [Related]
5. HLA-B27 in inbred and non-inbred transgenic mice. Cell surface expression and recognition as an alloantigen in the absence of human beta 2-microglobulin.
Taurog JD; Lowen L; Forman J; Hammer RE
J Immunol; 1988 Dec; 141(11):4020-3. PubMed ID: 3053904
[TBL] [Abstract][Full Text] [Related]
6. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
[TBL] [Abstract][Full Text] [Related]
7. Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis.
Vázquez MN; López de Castro JA
Arthritis Rheum; 2005 Oct; 52(10):3290-9. PubMed ID: 16200602
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice.
Khare SD; Luthra HS; David CS
Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652
[TBL] [Abstract][Full Text] [Related]
9. The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex.
Tran TM; Ivanyi P; Hilgert I; Brdicka T; Pla M; Breur B; Flieger M; Ivasková E; Horejsí V
Immunogenetics; 2001 Aug; 53(6):440-6. PubMed ID: 11685454
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE
J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755
[TBL] [Abstract][Full Text] [Related]
11. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability.
Dhaenens M; Fert I; Glatigny S; Haerinck S; Poulain C; Donnadieu E; Hacquard-Bouder C; André C; Elewaut D; Deforce D; Breban M
Arthritis Rheum; 2009 Sep; 60(9):2622-32. PubMed ID: 19714626
[TBL] [Abstract][Full Text] [Related]
13. Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice.
Nickerson CL; Luthra HS; David CS
Ann Rheum Dis; 1990 Jun; 49 Suppl 1():426-33. PubMed ID: 2115764
[TBL] [Abstract][Full Text] [Related]
14. Cellular expression or binding of desLys58-beta2 microglobulin is not dependent on the presence of the tri-molecular MHC class I complex.
Wang M; Corlin DB; Heegaard NH; Claesson MH; Nissen MH
Scand J Immunol; 2008 Feb; 67(2):105-12. PubMed ID: 18069937
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking endogenous major histocompatibility complex class II develop arthritis resembling psoriatic arthritis at an advanced age.
Bárdos T; Zhang J; Mikecz K; David CS; Glant TT
Arthritis Rheum; 2002 Sep; 46(9):2465-75. PubMed ID: 12355495
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules.
Martayan A; Fraioli R; Giorda E; Setini A; Ciccarelli G; Delfino L; Ferrara GB; Giacomini P
Br J Cancer; 1999 May; 80(5-6):639-49. PubMed ID: 10360639
[TBL] [Abstract][Full Text] [Related]
17. Free HLA class I heavy chain-carrying monocytes--a potential role in the pathogenesis of spondyloarthropathies.
Tsai WC; Chen CJ; Yen JH; Ou TT; Tsai JJ; Liu CS; Liu HW
J Rheumatol; 2002 May; 29(5):966-72. PubMed ID: 12022359
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of iron overload in beta2-microglobulin-deficient mice.
Muckenthaler MU; Rodrigues P; Macedo MG; Minana B; Brennan K; Cardoso EM; Hentze MW; de Sousa M
Blood Cells Mol Dis; 2004; 33(2):125-31. PubMed ID: 15315790
[TBL] [Abstract][Full Text] [Related]
19. The role of MHC class I heterodimer expression in mouse ankylosing enthesopathy.
Weinreich SS; Hoebe-Hewryk B; van der Horst AR; Boog CJ; Ivanyi P
Immunogenetics; 1997; 46(1):35-40. PubMed ID: 9148786
[TBL] [Abstract][Full Text] [Related]
20. β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system.
Ardeniz Ö; Unger S; Onay H; Ammann S; Keck C; Cianga C; Gerçeker B; Martin B; Fuchs I; Salzer U; İkincioğulları A; Güloğlu D; Dereli T; Thimme R; Ehl S; Schwarz K; Schmitt-Graeff A; Cianga P; Fisch P; Warnatz K
J Allergy Clin Immunol; 2015 Aug; 136(2):392-401. PubMed ID: 25702838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
